{"id":"W4416083447","doi":"10.1016/j.jid.2025.09.150","title":"135 Randomized Phase 3 trial of spesolimab in patients with ulcerative pyoderma gangrenosum: A study protocol","year":2025,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Protocol (science); Randomized controlled trial; Pyoderma; Phases of clinical research; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003182641,0.002899756,0.003623195,0.0007958986,0.0009394604,0.001679415,0.001289698,0.002460234,0.02818968],"category_scores_gemma":[0.002485831,0.001323439,0.003625079,0.0007128939,0.00150022,0.0009857904,0.00083832,0.003986988,0.003484366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002027361,"about_ca_system_score_gemma":0.004858259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002016911,"about_ca_topic_score_gemma":0.005107532,"domain_scores_codex":[0.9982393,0.0008732371,0.000120523,0.0002608207,0.0001462239,0.0003598887],"domain_scores_gemma":[0.9989063,0.0002810067,0.0002165567,0.0001173155,0.00009493707,0.0003839228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9771158,0.002760883,0.000302917,0.001124945,0.001077285,0.00005256685,0.00004287813,0.0004718041,0.001620822,0.0004452779,0.003893527,0.01109129],"study_design_scores_gemma":[0.9907048,0.007060565,0.0003821296,0.00003228425,0.0002175141,0.00001054092,0.000004842195,0.0001110749,0.0000814501,0.0001327364,0.00125351,0.00000851706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.4174023,0.01000287,0.01074281,0.004615665,0.003187567,0.4994191,0.02505491,0.001631191,0.0279436],"genre_scores_gemma":[0.5541158,0.003973232,0.01496875,0.008699649,0.001077279,0.3916033,0.008256647,0.0001510602,0.01715423],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.02818968,"threshold_uncertainty_score":0.09430391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0123921741501593,"score_gpt":0.323473439511924,"score_spread":0.3110812653617647,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}